Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Abbott Laboratories

Market Cap 15TCr 13TCr 12TCr 12TCr 22TCr 14,53100Cr 22TCr 1,47500Cr 57TCr 7,15200Cr 58TCr 57TCr 24,83400Cr P/E 2026 *
22.2x
P/E 2027 * 19.1x
Enterprise Value 17TCr 14TCr 13TCr 13TCr 23TCr 15,63700Cr 24TCr 1,58800Cr 62TCr 7,69700Cr 62TCr 61TCr 26,72500Cr EV / Sales 2026 *
3.3x
EV / Sales 2027 * 2.97x
Free-Float
86.73%
Yield 2026 *
2.88%
Yield 2027 * 3.07%
1 day+0.71%
1 week-2.07%
Current month+5.19%
1 month+2.16%
3 months-15.98%
6 months-28.28%
Current year-28.28%
1 week 70.5
Extreme 70.5
71
1 month 67.5
Extreme 67.5
74.5
Current year 65
Extreme 65
100
1 year 65
Extreme 65
106
3 years 65
Extreme 65
106
5 years 65
Extreme 65
128
10 years 34.75
Extreme 34.75
128
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.71%-2.07% - - 15TCr
+1.54%-1.07%-8.11%-10.79% 10TCr
-4.45%+3.12%+61.36%+57.49% 5.65TCr
-1.90%-3.49%-7.43%+47.34% 5.29TCr
+1.67%-1.55%-14.51%-43.86% 3.97TCr
-1.32%-1.83% - - 3.04TCr
+1.74%-3.85%-9.41%-44.24% 2.8TCr
+1.35%-0.26%+51.96%-10.42% 2.32TCr
-1.53%+1.14%-15.21%-5.72% 2.03TCr
+1.61%-2.38%-14.03%-5.14% 1.97TCr
Average -0.06%-1.39%+5.58%-1.92% 4.14TCr
Weighted average by Cap. +0.04%-1.23%+5.94%+3.57%

Financials

2026 *2027 *
Net sales 5.03TCr 4.38TCr 4.06TCr 3.8TCr 7.13TCr 4,74500Cr 7.17TCr 48TCr 19TCr 2,33600Cr 19TCr 18TCr 8,11000Cr 5.48TCr 4.78TCr 4.42TCr 4.14TCr 7.77TCr 5,17000Cr 7.82TCr 52TCr 20TCr 2,54500Cr 21TCr 20TCr 8,83600Cr
Net income 701.88Cr 611.97Cr 566.78Cr 530.58Cr 995.07Cr 66TCr 1TCr 6.72TCr 2.61TCr 33TCr 2.63TCr 2.58TCr 1,13200Cr 839.23Cr 731.73Cr 677.7Cr 634.41Cr 1.19TCr 79TCr 1.2TCr 8.04TCr 3.12TCr 39TCr 3.15TCr 3.08TCr 1,35300Cr
Net Debt 1.17TCr 1.02TCr 946.94Cr 886.46Cr 1.66TCr 1,10600Cr 1.67TCr 11TCr 4.35TCr 54TCr 4.4TCr 4.31TCr 1,89100Cr 888.3Cr 774.51Cr 717.32Cr 671.5Cr 1.26TCr 84TCr 1.27TCr 8.51TCr 3.3TCr 41TCr 3.33TCr 3.26TCr 1,43300Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
Date Price Change
19/26/19 71.00 CHF 0.00%
18/26/18 71.00 CHF 0.00%
17/26/17 71.00 CHF 0.00%
16/26/16 71.00 CHF +0.71%
15/26/15 70.50 CHF -2.76%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
88.41USD
Average target price
116.54USD
Spread / Average Target
+31.82%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!